ALDH18A1 and Hepatic fibrosis: Lemoine et al. found that the GPR is a more accurate routine laboratory marker than APRI and FIB-4 to stage liver fibrosis in patients with CHB in West Africa, which was useful in predicting the levels of liver fibrosis of CHB patients [37].